Assessing losses related to actual disease incidence in a region's population: an economic aspect (a case study of the Altai region of Russia)

The analysis of the economic losses associated with the actual disease incidence in the region's population by the following classes of diseases "Poisoning by drugs, medicaments and biological substances” (T36-T50) and "Toxic effects of substances chiefly nonmedicinal as to source” (T51-T65), which includes an assessment of production losses in the region's economy in value terms and an assessment of changes in cash flows in the RF budgets (tax revenues) is presented in this work. The period of time covered by the analysis by the classes of diseases is 5 years (from 2007 to 2011). The greatest region's gross regional product (GRP) losses related to the actual disease incidence in the population by classes of diseases T36-T50 and T51-T65 GRP over the analyzed time period were seen in 2011.